A factor contained in plasma is required for IGF binding protein‐1 to potentiate the effect of IGF‐I on smooth muscle cell DNA synthesis

Journal of Cellular Physiology

Volumn 145, Issue 1, 1990, Pages 129-135

  Clemmons, D R ^a   Gardner, L I ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; RADIOISOTOPE; SOMATOMEDIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; SWINE; VASCULAR SMOOTH MUSCLE;

ANIMAL; BIOLOGICAL FACTORS; CARRIER PROTEINS; DNA; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTORS; G1 PHASE; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; INSULIN-LIKE GROWTH-FACTOR-BINDING PROTEINS; MUSCLE, SMOOTH; PLATELET-DERIVED GROWTH FACTOR; SUPPORT, U.S. GOV'T, P.H.S.; SWINE; THYMIDINE; TRITIUM;

ANIMALIA; SUS SCROFA;

EID: 0025045915     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.1041450118     Document Type: Article

References (27)

1. Effects of anabolic agents on protein break down in L6 myoblasts
2. Insulin like growth factor I (IGF‐I)‐binding protein complex is a better mitogen than free IGF‐I
3. Cloning, characterization and expression of a human insulin‐like growth factor binding protein
4. Nucleotide sequence and expression of a cDNA cloning encoding a fetal rat binding protein for insulin‐like growth factors
5. Purification of a 31000 dalton insulin like growth factor binding protein from human amniotic fluid
6. Exposure to platelet derived growth factor modulates porcine aortic smooth muscle cell response to somatome‐din‐C
7. Somatomedin‐C binding to cultured human fibroblasts is dependent upon donor age and culture density
8. Discrete alterations of the insulin‐like growth factor I molecule which alter its affinity for insulin‐like growth factor binding proteins result in changes in bioactivity
9. Insulin like growth factor I/somatomedin‐C (IGF‐I/sm‐C) and glucocorticoids synergistically regulate mitosis in component human fibroblasts
10. Growth hormone dependent insulin‐like growth factor binding protein both inhibits and potentiates IGF‐I stimulated DNA synthesis in skin fibroblasts
11. Partial purification and characterization of a binding protein for insulin‐like activity in human amniotic fluid. A possible inhibitor of insulin‐like activity
12. An insulin‐like growth factor binding protein enhances the biologic response to IGF‐I
13. Analysis of serum insulin‐like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies
14. Inhibition of biologic activity of multiplication stimulation activity by binding to its carrier protein
15. Plasminogen activator is associated with the extracellular matrix of cultured bovine smooth muscle cells
16. Insulin like growth factor IGF binding protein complementary deoxyribonucleic acid from human Hep G2 hepatoma cells: Predicted protein sequence suggests an IGF binding domain different from those of IGF‐I and IGF‐II receptors
17. Epidermal growth factor and somatomedin‐C regulate G1 progression in competent BALB/C 3T3 cell
18. A low molecular weight insulin like growth factor binding protein from rat cDNA cloning and tissue distribution of its messenger RNA
19. Insulin like growth factor binding protein secretion by muscle cells: Effect of cellular differentiation and proliferation
20. Insulin like growth factors: Biosynthesis, receptors and carrier proteins
21. Insulin‐like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF‐I in cultured choriocarcinoma cells
22. The smooth muscle cell: Growth of smooth muscle in cultures and formation of elastic fibers
23. Arg‐Gly‐Asp: A versatile recognition signal
24. Dual control of cell growth by somatomedin and platelet derived growth factor
25. The somatomedins: Biological actions and physiological control mechanisms
26. Inhibition of action of non suppressible insulin‐like activity on isolated fat cells by binding to its carrier protein
27. Biological and immunological properties of insulin‐like growth factors (IGF) I and II